Pharma Journalist 9027 posts 0 comments

Novartis announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto (sacubitril/valsartan): to reduce the risk of…
Read More...

AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions,  announced a new collaboration with AstraZeneca, a global science-led…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies…
Read More...

Avexegen Therapeutics Inc. announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's Small Business Innovation Research Program (SBIR)…
Read More...

SMi Reports: SMi Group is proud to introduce some insightful content from our chair and expert speaker of the Pre-filled Syringes East Coast virtual conference 2021 The upcoming…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, announced an…
Read More...

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of…
Read More...

SMi Reports: Bringing together industry experts to discuss the challenges and drivers of the industry This conference is a must-attend show for anyone involved in the parallel trade…
Read More...

The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults…
Read More...

MindMed a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with…
Read More...